PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90696095 |
Filing Date: 05/07/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90696095 |
---|---|
MARK INFORMATION | |
*MARK | PREVAIL |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | PREVAIL |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | RIS RX |
*MAILING ADDRESS | 351 Hospital Rd, Suite 306 |
*CITY | Newport Beach |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
92663 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | www.risrx.com |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | California |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 036 |
*IDENTIFICATION | Providing technology-infused solutions such as government screening, eligibility, and benefit investigation services including patient reimbursement and insurance coverage for pharmaceuticals and medical devices |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 02/04/2021 |
FIRST USE IN COMMERCE DATE | At least as early as 02/04/2021 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-6877243245-202105071 21006136781_._PreVail_mar k_-_screen_shot.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\906\960\90696095\xml1\ APP0003.JPG |
SPECIMEN DESCRIPTION | Screen shot of webpage |
WEBPAGE URL | www.risrx/solutions/core |
WEBPAGE DATE OF ACCESS | 05/07/2021 |
INTERNATIONAL CLASS | 045 |
*IDENTIFICATION | Consulting services, namely, conducting insurance benefit investigations for pharmaceutical and biotechnology companies |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 02/04/2021 |
FIRST USE IN COMMERCE DATE | At least as early as 02/04/2021 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-1-6877243245-2021050 7121006136781_._PreVail_m ark_-_screen_shot.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\906\960\90696095\xml1\ APP0004.JPG |
SPECIMEN DESCRIPTION | Screenshot of website |
WEBPAGE URL | risrx.com/solutions/core |
WEBPAGE DATE OF ACCESS | 05/07/2021 |
ATTORNEY INFORMATION | |
NAME | Sandra G. Gibbs |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Mulcahy LLP |
STREET | 4 Park Plaza, Suite 1950 |
CITY | Irvine |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 92614 |
PHONE | 949-252-9377 |
EMAIL ADDRESS | sgibbs@mulcahyllp.com |
CORRESPONDENCE INFORMATION | |
NAME | Sandra G. Gibbs |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | sgibbs@mulcahyllp.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | bcalvert@mulcahyllp.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
SIGNATURE | /Sandra G Gibbs/ |
SIGNATORY'S NAME | Sandra G. Gibbs |
SIGNATORY'S POSITION | Attorney of record |
SIGNATORY'S PHONE NUMBER | 949-252-9377 |
DATE SIGNED | 05/07/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90696095 |
Filing Date: 05/07/2021 |
The applicant's current Correspondence Information: |
Sandra G. Gibbs |
PRIMARY EMAIL FOR CORRESPONDENCE: sgibbs@mulcahyllp.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bcalvert@mulcahyllp.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|